טוען...
Clinical Predictors of Response to Clozapine in Patients with Treatment Resistant Schizophrenia
OBJECTIVES: Despite clozapine’s superior clinical efficacy in Treatment Resistant Schizophrenia (TRS), its adverse effects, need for periodic leukocyte monitoring, cost and variable clinical outcomes make the therapeutic decision making process difficult and mandate a clinical need to predict its tr...
שמור ב:
| הוצא לאור ב: | Psychopharmacol Bull |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MedWorks Media Global
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5044549/ https://ncbi.nlm.nih.gov/pubmed/27738362 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|